Showing results (2011-2020 of 2,044) with videos related to
Sort By:
Pageof 205
The Journal of Allergy and Clinical Immunology|February 1, 2024
Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locusCarina M Mathey, Carlo Maj, Niclas Eriksson, et al.Nature Communications|February 24, 2025
Insights from a methylome-wide association study of antidepressant exposureE Davyson, X Shen, F Huider, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 2020
Outcome measurement in functional neurological disorder: a systematic review and recommendationsSusannah Pick, David G Anderson, Ali A Asadi-Pooya, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2023
Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitisPeter White, Susan Abbey, Brian Angus, et al.The Lancet. Neurology|August 10, 2019
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trialMichael G Hanna, Umesh A Badrising, Olivier Benveniste, et al.JAMA Neurology|November 23, 2020
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialBrian J Wainger, Eric A Macklin, Steve Vucic, et al.Neurology|February 18, 2021
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENTAnthony A Amato, Michael G Hanna, Pedro M Machado, et al.Nature Medicine|September 23, 2024
Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reductionGreta K Wood, Brendan F Sargent, Zain-Ul-Abideen Ahmad, et al.Ebiomedicine|May 9, 2026
DNA methylation signatures associated with bipolar disorder in peripheral blood improve prediction modelsMarkos Tesfaye, Anne-Kristin Stavrum, Kira D Höffler, et al.International Journal of Clinical and Health Psychology : IJCHP|April 16, 2024
MIR137 polygenic risk for schizophrenia and ephrin-regulated pathway: Role in lateral ventricles and corpus callosum volumeG A M Blokland, N Maleki, J Jovicich, et al.Pageof 205